Mayo Clinic, 200 First Street SW

Rochester, Minnesota 55905

0 studies enrolling now · 3 studies all time

What they study most

Breast Cancer, Celiac Disease, Parkinson Disease

Studies at this site

• Phase 1/2a Clinical Trial of PR001 (LY3884961) in Patients With Parkinson's Disease With at Least One GBA1 Mutation (PROPEL) — Running, not enrolling
• Trial of Sacituzumab Govitecan in Participants With Refractory/Relapsed Metastatic Triple-Negative Breast Cancer (TNBC) — Completed
• Latiglutenase as a Treatment for Celiac Disease — Completed